Immunization and transplantation--what is new and what is coming?

Area of Science:

• Pediatric immunology and transplantation
• Infectious disease prevention
• Vaccinology

Background:

• Pediatric transplant recipients are at high risk of infections.
• Immunization is crucial for preventing infections in this population.
• Current vaccine availability and schedules need optimization for transplant candidates and recipients.

Purpose of the Study:

• To review current and emerging immunization strategies for pediatric transplant recipients.
• To discuss the integration of new vaccines, such as pertussis and human papillomavirus (HPV) vaccines, into pediatric transplant care.
• To explore the potential impact of future vaccines, including those for cytomegalovirus (CMV) and Epstein-Barr virus (EBV), on this patient group.

Main Methods:

• Literature review of recent studies on pediatric transplantation and vaccinology.
• Analysis of new and upcoming vaccine recommendations relevant to pediatric transplant candidates and recipients.
• Discussion of practical considerations for vaccine delivery in this immunocompromised population.

Main Results:

• New immunization schedules, including pertussis vaccines for adolescents, are being developed.
• Newly available vaccines, such as the HPV vaccine, offer expanded protection.
• Future vaccines targeting CMV and EBV hold significant promise for reducing post-transplant complications.

Conclusions:

• Optimizing immunization schedules and incorporating new vaccines are vital for reducing infection risks in pediatric transplant recipients.
• Proactive vaccine strategies, including those for less common infections and future targets like CMV and EBV, are essential for improving long-term outcomes.
• Further research and clinical trials are needed to establish optimal vaccine protocols for this unique patient population.